Acorah Software Products - Accounts Production 15.0.500 false true false 10 November 2022 31 March 2024 31 March 2024 OC444605 Vauban Poliorcetics LLP Aescuvest GmbH iso4217:GBP iso4217:EUR iso4217:USD xbrli:shares xbrli:pure xbrli:pure OC444605 2022-11-09 OC444605 2024-03-31 OC444605 2022-11-10 2024-03-31 OC444605 frs-bus:LimitedLiabilityPartnershipLLP 2022-11-10 2024-03-31 OC444605 frs-bus:LimitedLiabilityPartnershipsSORP 2022-11-10 2024-03-31 OC444605 frs-bus:FilletedAccounts 2022-11-10 2024-03-31 OC444605 frs-bus:SmallEntities 2022-11-10 2024-03-31 OC444605 frs-bus:AuditExempt-NoAccountantsReport 2022-11-10 2024-03-31 OC444605 frs-bus:SmallCompaniesRegimeForAccounts 2022-11-10 2024-03-31 OC444605 frs-countries:EnglandWales 2022-11-10 2024-03-31 OC444605 frs-bus:PartnerLLP1 2022-11-10 2024-03-31 OC444605 frs-bus:PartnerLLP2 2022-11-10 2024-03-31
Registered number: OC444605
Health Innovations Invest V LLP
Unaudited Financial Statements
For the Period 10 November 2022 to 31 March 2024
Vauban Technologies Limited
Contents
Page
Balance Sheet 1
Notes to the Financial Statements 2
Page 1
Balance Sheet
Registered number: OC444605
31 March 2024
Notes $ $
CURRENT ASSETS
Investments 4 600,130
Cash at bank and in hand 49,240
649,370
NET CURRENT ASSETS (LIABILITIES) 649,370
TOTAL ASSETS LESS CURRENT LIABILITIES 649,370
NET ASSETS ATTRIBUTABLE TO MEMBERS 649,370
REPRESENTED BY:
Equity
Members' other interests
Members' capital 725,661
Other reserves (76,291)
649,370
TOTAL MEMBERS' INTEREST
Members' other interests 649,370
649,370
For the period ending 31 March 2024 the LLP was entitled to exemption from audit under section 477 of the Companies Act 2006 (as applied by the Limited Liability Partnerships (Accounts and Audit) (Application of Companies Act 2006) Regulations 2008 applicable to LLPs subject to the small LLPs regime.)
The members acknowledge their responsibilities for complying with the requirements of the Act (as applied to LLPs) with respect to accounting records and the preparation of accounts.
These accounts have been prepared and delivered in accordance with the provisions applicable to LLPs subject to the small LLPs regime.
The LLP has taken advantage of section 444(1) of the Companies Act 2006 and opted not to deliver to the registrar a copy of the LLP's Profit and Loss Account.
On behalf of the members
Aescuvest GmbH
Designated Member
06/08/2024
The notes on page 2 form part of these financial statements.
Page 1
Page 2
Notes to the Financial Statements
1. General Information
Health Innovations Invest V LLP is a limited liability partnership, incorporated in England & Wales, registered number OC444605 . The Registered Office is Censeo House, 6 Peters Street, St Albans, AL1 3LF.
2. Accounting Policies
2.1. Basis of Preparation of Financial Statements
The financial statements are prepared under the historical cost convention and in accordance with applicable United Kingdom accounting standards, including Financial Reporting Standard 102 for small limited liability partnerships regime - The Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102), The Statement of Recommended Practice 'Accounting by Limited Liability Partnerships' issued in December 2021 (SORP) and the Companies Act 2006 (as applied to LLPs).
The financial statements are prepared in sterling which is the functional currency of the LLP.
3. Average Number of Employees
Average number of employees, including members with contracts of employment, during the period was: NIL
-
4. Current Asset Investments
31 March 2024
$
Unlisted investments 600,130
Page 2